Overview of Dr. Wagner
Dr. Jonathan Wagner is a pediatric cardiologist in Kansas City, MO and is affiliated with multiple hospitals in the area, including Children's Mercy Hospital Kansas City, Children's Mercy Hospital Kansas City, and Children's Mercy Hospital Kansas City. He received his medical degree from Kansas City University of Medicine and Biosciences and has been in practice 10 years. He specializes in inpatient pediatric cardiology and pediatric cardiac genetics. He is experienced in clinical pharmacology and pharmacogenetics.
Office
2401 Gillham Rd.
Kansas City, MO 64108
Education & Training
- Children's Mercy Kansas City2011 - 2014
- Children’s Mercy HospitalFellowship, Pediatric Cardiology, 2011 - 2013
- Penn State Milton S Hershey Medical CenterFellowship, Pediatric Cardiology, 2010 - 2011
- Children’s Mercy HospitalResidency, Pediatrics, 2007 - 2010
- Kansas City University of Medicine and Biosciences College of Osteopathic MedicineClass of 2007
- University of MissouriB.S., Biochemistry, Magna Cum Laude Latin Honors, 1999 - 2003
Certifications & Licensure
- KS State License 2013 - 2025
- MO State License 2009 - 2025
- PA State License 2010 - 2011
- American Board of Pediatrics Pediatrics
- American Board of Pediatrics Pediatric Cardiology
Awards, Honors, & Recognition
- Children’s Mercy Hospital Department of Pediatrics Research Achievement Award 2018
- Fellow Educator of the Year Nominee Children’s Mercy Hospital and Clinics, 2013
- Alpha Omega Alpha University of Missouri-Kansas City, 2013
- Join now to see all
Publications & Presentations
PubMed
- 1 citationsFrom Dose to Exposure: Shifting the Paradigm of Pediatric Clinical Pharmacology Research and Education.Ronaldo Morales Junior, Victor Amajor, Kelli Paice, Kathryn E Kyler, H Rhodes Hambrick
Clinical Pharmacology and Therapeutics. 2024-09-01 - Pediatric Beta Blocker Therapy: A Comprehensive Review of Development and Genetic Variation to Guide Precision-Based Therapy in Children, Adolescents, and Young Adults.Mollie Walton, Jonathan B Wagner
Genes. 2024-03-20 - Genetic Variation Influence on Atorvastatin Systemic Exposure in Pediatric Hypercholesterolemia.Jonathan B Wagner, Susan Abdel-Rahman, Geetha Raghuveer, Andrea Gaedigk, Erin C Boone
Genes. 2024-01-15
Journal Articles
- An Adolescent with Possible Arrhythmogenic Right Ventricular Dysplasia and Long QT Syndrome: Evaluation and ManagementTisma-Dupanovic S, Wagner J, Shah S, Huang D, Ann Noninvasive Electrocardiol, 1/1/2013
- Pre-procedural and Intra-procedural Predictors of Outcome in Pulmonary Atresia-Intact Ventricular Septum Following Radiofrequency Perforation and Balloon ValvuloplastyWagner J, Carlson KM, Hubbell MM, Bingler MA, Kaine SF, Catheter Cardiovasc Interv, 1/1/2012
- Pulse Oximetry ScreeningDrake W, Wagner J, Peds Lines Missouri AAP Newsletter, Spring/Summer, 1/1/2012
Books/Book Chapters
Abstracts/Posters
- “Influence of ontogeny and genetic variation on molecular and clinical elements of dyslipidemia in children.” In vitro and in vivo analysis of ontogeny of transporters...Keller S, Wagner J, Gaedigk R, Dai H, Leeder JS, American Society of Health-system Pharmacists (ASHP) Midyear Clinical Meeting, 1/1/2014
- Statin PharmacogenomicsWagner J, The Eunice Kennedy Shriver, National Institute of Child Health and Human Development, T32 Pediatric Clinical Pharmacology Fellow Meeting, 1/22/2013
- Clinical Impact of Genetic Variation in Statin DispositionWagner J, Amongst the Pediatric Population, First Annual Children’s Mercy Cardiac Forum, 1/12/2013
- Join now to see all
Lectures
- Statin Pharmacogenomics1/15/2014
- Pharmacotherapy of Heart Disease in the ICNChildren’s Mercy Hospital and Clinics - 1/6/2014
- Congenital Heart Disease OverviewUniversity of Missouri-Kansas City School of Pharmacy - 1/28/2013
- Join now to see all
Grant Support
- GOLDILOKs: Genomic- and Ontogeny-Linked Dose Individualization and cLinical Optimization for Kids Pilot Project: Validation of OATP Endogenous Biomarkers in ChildrenNIH-NICHD2018–Present
- Imaging and Biomarker Evaluation of Hepatic Stiffness in Children Enrolled in the Fontan Udenafil Exercise Longitudinal Study (FALD Ancillary Study)NHLBI (PHN)2018–Present
- A Phase III Safety Extension Study of Udenafil in Adolescents with Single Ventricle Physiology after Fontan Palliation (FUEL Extension)NIH-NHLBI (PHN)2017–Present
- Statin Optimization in PediatricsFrontiers Clinical and Translational Science Institute2017–Present
- Fontan Udenafil Exercise Longitudinal (FUEL) Assessment TrialNHLBI (PHN)2015–Present
Committees
- Editorial Board, Clinical and Translational Science 2018 - Present
- Primary Reviewer, Internal Research Awards Special Emphasis Panel, Children’s Mercy Hospital 2018 - Present
- Co-Chair, Heart Center Strategic Planning Committee, Raising Academic Profile (Research) Section, Children’s Mercy Hospital 2018 - Present
- Member, American Heart Association Kansas City Board of Directors 2018 - Present
- Member, Publications and Communications Workgroup, American Academy of Pediatrics Section on Cardiology and Cardiac Surgery 2016 - Present
- Chair, Children’s Mercy Hospital Cardiac Forum Pre-conference, Children’s Mercy Hospital 2016 - Present
- Advocacy Committee, American Heart Association Kansas Delegation 2015 - Present
- Editorial Board and Reviewer, Frontiers in Pharmacology Obstetric and Pediatric Pharmacology Section 2014 - Present
- Member, Clinical Fellowship Research Award Selection Committee, Department of Research, Children’s Mercy Hospital 2014 - Present
- Member, Fellowship Clinical Competency Committee, Division of Cardiology, Children’s Mercy Hospital 2013 - Present
Professional Memberships
- Member
- Fellow
- Member
- Member
- Alpha Omega AlphaMember
- American Society for Clinical Pharmacology and TherapeuticsMember
- Society for Cardiovascular Angiography and InterventionsMember
- University of Missouri-Columbia Alumni AssociationMember
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: